Clinical Trial Update: Pathways to Advance Targeted and Helpful Serious Illness Conversations (PATH-SIC) [NA]

View source ↗

Summary

This clinical trial update reports on the PATH-SIC study from Dana-Farber Cancer Institute, aimed at advancing targeted, serious-illness conversations for patie…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer
• Gastrointestinal Cancer
• Genitourinary Cancer
• Gynecologic Cancer
• Thoracic Cancer

Snippet

Sponsor: Dana-Farber Cancer Institute | Conditions: Breast Cancer, Gastrointestinal Cancer | NA | Status: ACTIVE_NOT_RECRUITING